Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.

Cardiac Arrest or DeathMyocardial Infarction

Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

JAMA.

Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz A, Masoudi FA, Messenger JC, Parzynski CS, Ngufor C, Girotra S, Amin AP, Shah ND, Desai NR

doi: 10.1001/jama.2020.0254.

Myocardial Infarction

Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction

J Am Coll Cardiol.

Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot JP, Kimmoun A, Cariou A, Lassus J, Harjola VP, Meziani F, Louis G, Rossignol P, Duarte K, Girerd N, Mebazaa A, Vignon P, Collaborators

doi: 10.1016/j.jacc.2018.04.051.

Myocardial Infarction

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

Eur Heart J Acute Cardiovasc Care.

Zeymer U, Bueno H, Granger CB, Hochman J, Huber K, Lettino M, Price S, Schiele F, Tubaro M, Vranckx P, Zahger D, Thiele H

doi: 10.1177/2048872619894254.

Myocardial InfarctionTherapy and Intervention

Impact of microaxillar mechanical left ventricular support on renal resistive index in patients with cardiogenic shock after myocardial infarction: a pilot trial to predict renal organ dysfunction in cardiogenic shock

Eur Heart J Acute Cardiovasc Care.

Markus B, Patsalis N, Chatzis G, Luesebrink U, Ahrens H, Schieffer B, Karatolios K

doi: 10.1177/2048872619860218.

Myocardial Infarction

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

N Engl J Med.

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U; CULPRIT-SHOCK Investigators

doi: 10.1056/NEJMoa1710261.

Therapy and Intervention

Multi- Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock

JACC Cardiovasc Interv.

Lemor A, Basir MB, Patel K, Kolski B, Kaki A, Kapur N, Riley R, Finley J, Goldsweig A, Aronow HD, Belford PM, Tehrani B, Truesdell AG, Lasorda D, Bharadwaj A, Hanson I, LaLonde T, Gorgis S, O'Neill W, National Cardiogenic Shock Initiative Investigators

doi: 10.1016/j.jcin.2020.03.012.

Cardiac Arrest or DeathMyocardial Infarction

Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction-related cardiogenic shock from 2005-2017: A nationwide cohort study

Am Heart J.

Lauridsen MD, Rorth R, Lindholm MG, Kjaergaard J, Schmidt M, Møller JE, Hassager C, Torp-Pedersen C, Gislason G, Køber L, Fosbol EL

doi: 10.1016/j.ahj.2020.08.012.

Myocardial InfarctionTherapy and Intervention

Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial

Am Heart J.

Guedeney P, Thiele H, Kerneis M, Barthélémy O, Baumann S, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Piek JJ, Landmesser U, Hauguel-Moreau M, Zeitouni M, Silvain J, Lattuca B, Windecker S, Collet JP, Desch S, Zeymer U, Montalescot G, Akin I, CULPRIT-SHOCK Investigators.

doi: 10.1016/j.ahj.2020.04.014.

Cardiac Arrest or DeathMyocardial Infarction

Effects of ON-Hours Versus OFF-Hours Admission on Outcome in Patients With Myocardial Infarction and Cardiogenic Shock: Results From the CULPRIT-SHOCK Trial

Circ Cardiovasc Interv.

Sag CM, Zeymer U, Ouarrak T, Schneider S, Montalescot G, Huber K, Fuernau G, Freund A, Feistritzer HJ, Desch S, Thiele H, Maier LS

doi: 10.1161/CIRCINTERVENTIONS.

Related content

Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

Impact of microaxillar mechanical left ventricular support on renal resistive index in patients with cardiogenic shock after myocardial infarction: a pilot trial to predict renal organ dysfunction in cardiogenic shock

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

Multi- Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock

Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction-related cardiogenic shock from 2005-2017: A nationwide cohort study

Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial

Effects of ON-Hours Versus OFF-Hours Admission on Outcome in Patients With Myocardial Infarction and Cardiogenic Shock: Results From the CULPRIT-SHOCK Trial